Filters

1020 Results

relevance


Enlifta

Ad Alert

Enlifta

FDA targets supplement sellers on Amazon making unapproved disease-treatment claims.

Discover CBD

Ad Alert

Discover CBD

Unapproved drug treatment claims remain in wake of FDA warning letter.

Comment at FDA Public Meeting on Dietary Supplements

Blog

Comment at FDA Public Meeting on Dietary Supplements

Comment made by TINA.org executive director, Bonnie Patten at the FDA’s public meeting on Responsible Innovation in Dietary Supplements held on May 16, 2019. Thank you for the opportunity to…

NeuroBrocc

Ad Alert

NeuroBrocc

Unapproved and unsubstantiated claims abound in marketing of broccoli-based supplement.

BullyKamp

Ad Alert

BullyKamp

FDA warns that this pet company’s marketing bites off more than it can chew.

Fertilix

Ad Alert

Fertilix

FDA warns company behind male fertility supplement about unapproved drug claims.

Target

Brands

Target

TINA.org investigated Target’s website – www.target.com – and found that false and deceptive Made in the USA labeling issues were widespread on its site, including product specifications that falsely stated…

Show More